NDC 63402-020
KYNMOBI
Apomorphine Hydrochloride
KYNMOBI is a Sublingual Film, Soluble in the Human Prescription Drug category. It is labeled and distributed by Sunovion Pharmaceuticals Inc.. The primary component is Apomorphine Hydrochloride.
| Product ID | 63402-020_25c9b073-ff62-45ac-a969-bbc9c77c91ee |
| NDC | 63402-020 |
| Product Type | Human Prescription Drug |
| Proprietary Name | KYNMOBI |
| Generic Name | Apomorphine Hydrochloride |
| Dosage Form | Film, Soluble |
| Route of Administration | SUBLINGUAL |
| Marketing Start Date | 2020-05-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA210875 |
| Labeler Name | Sunovion Pharmaceuticals Inc. |
| Substance Name | APOMORPHINE HYDROCHLORIDE |
| Active Ingredient Strength | 20 mg/1 |
| Pharm Classes | Dopamine Agonists [MoA], Dopaminergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 63402-020-30
30 POUCH in 1 CARTON (63402-020-30) > 1 FILM, SOLUBLE in 1 POUCH (63402-020-01)
| Marketing Start Date | 2020-05-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 63402-020-01 [63402002001]
KYNMOBI FILM, SOLUBLE
| Marketing Category | NDA |
| Application Number | NDA210875 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-21 |
NDC 63402-020-30 [63402002030]
KYNMOBI FILM, SOLUBLE
| Marketing Category | NDA |
| Application Number | NDA210875 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-21 |
Drug Details
Medicade Reported Pricing
63402020830 APTIOM 800 MG TABLET
Pricing Unit: EA | Drug Type:
63402020660 APTIOM 600 MG TABLET
Pricing Unit: EA | Drug Type:
63402020430 APTIOM 400 MG TABLET
Pricing Unit: EA | Drug Type:
63402020230 APTIOM 200 MG TABLET
Pricing Unit: EA | Drug Type:
63402020100 LONHALA MAGNAIR 25 MCG STARTER
Pricing Unit: ML | Drug Type:
NDC Crossover Matching brand name "KYNMOBI" or generic name "Apomorphine Hydrochloride"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 63402-010 | KYNMOBI | apomorphine hydrochloride |
| 63402-015 | KYNMOBI | apomorphine hydrochloride |
| 63402-020 | KYNMOBI | apomorphine hydrochloride |
| 63402-025 | KYNMOBI | apomorphine hydrochloride |
| 63402-030 | KYNMOBI | apomorphine hydrochloride |
| 63402-088 | KYNMOBI | apomorphine hydrochloride |
| 63402-115 | KYNMOBI | KYNMOBI |
| 63402-110 | KYNMOBI | KYNMOBI |
| 63402-125 | KYNMOBI | KYNMOBI |
| 63402-188 | KYNMOBI | KYNMOBI |
| 63402-120 | KYNMOBI | KYNMOBI |
| 63402-130 | KYNMOBI | KYNMOBI |
| 27505-004 | APOKYN | APOMORPHINE HYDROCHLORIDE |
| 52817-720 | apomorphine hydrocloride | APOMORPHINE HYDROCHLORIDE |
| 10191-1225 | APOMORPHINUM MURIATICUM | APOMORPHINE HYDROCHLORIDE |
Trademark Results [KYNMOBI]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 KYNMOBI 88319635 not registered Live/Pending |
Sunovion Pharmaceuticals Inc. 2019-02-28 |
 KYNMOBI 87765645 not registered Live/Pending |
Sunovion Pharmaceuticals Inc. 2018-01-23 |
 KYNMOBI 86656477 not registered Dead/Abandoned |
SUNOVION PHARMACEUTICALS INC. 2015-06-09 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.